St. Johns Investment Management Company LLC Has $1.80 Million Stock Holdings in Stryker Co. (NYSE:SYK)

St. Johns Investment Management Company LLC decreased its stake in Stryker Co. (NYSE:SYK) by 3.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,022 shares of the medical technology company’s stock after selling 174 shares during the period. St. Johns Investment Management Company LLC’s holdings in Stryker were worth $1,797,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. grew its stake in Stryker by 0.5% during the third quarter. Vanguard Group Inc. now owns 30,665,520 shares of the medical technology company’s stock worth $8,379,967,000 after purchasing an additional 143,631 shares during the period. Price T Rowe Associates Inc. MD grew its stake in Stryker by 5.4% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 12,541,845 shares of the medical technology company’s stock worth $3,755,782,000 after purchasing an additional 642,178 shares during the period. Morgan Stanley grew its stake in Stryker by 4.4% during the third quarter. Morgan Stanley now owns 5,315,227 shares of the medical technology company’s stock worth $1,452,493,000 after purchasing an additional 223,728 shares during the period. Franklin Resources Inc. grew its stake in Stryker by 0.6% during the fourth quarter. Franklin Resources Inc. now owns 4,686,440 shares of the medical technology company’s stock worth $1,403,401,000 after purchasing an additional 29,209 shares during the period. Finally, Norges Bank acquired a new stake in Stryker during the fourth quarter worth approximately $1,260,562,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Wall Street Analyst Weigh In

SYK has been the subject of a number of research reports. Piper Sandler raised their price objective on Stryker from $375.00 to $380.00 and gave the company an “overweight” rating in a research note on Wednesday, May 1st. Robert W. Baird raised their price objective on Stryker from $367.00 to $378.00 and gave the company an “outperform” rating in a research note on Wednesday, May 1st. Needham & Company LLC raised Stryker from a “hold” rating to a “buy” rating and set a $392.00 price objective for the company in a research note on Wednesday, May 22nd. UBS Group raised their price objective on Stryker from $339.00 to $351.00 and gave the company a “neutral” rating in a research note on Wednesday, May 1st. Finally, BTIG Research raised their price objective on Stryker from $366.00 to $369.00 and gave the company a “buy” rating in a research note on Wednesday, May 1st. Four analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $370.58.

Stryker Stock Performance

Shares of Stryker stock opened at $340.79 on Thursday. The business’s fifty day simple moving average is $336.73 and its 200 day simple moving average is $332.95. The firm has a market capitalization of $129.82 billion, a P/E ratio of 38.90, a price-to-earnings-growth ratio of 2.67 and a beta of 0.92. Stryker Co. has a 12 month low of $249.98 and a 12 month high of $361.41. The company has a current ratio of 1.71, a quick ratio of 0.99 and a debt-to-equity ratio of 0.56.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Tuesday, April 30th. The medical technology company reported $2.50 EPS for the quarter, topping analysts’ consensus estimates of $2.36 by $0.14. The business had revenue of $5.24 billion for the quarter, compared to analyst estimates of $5.10 billion. Stryker had a return on equity of 23.05% and a net margin of 16.03%. Stryker’s quarterly revenue was up 9.7% compared to the same quarter last year. During the same period last year, the company posted $2.14 earnings per share. As a group, analysts anticipate that Stryker Co. will post 11.95 EPS for the current year.

Stryker Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 31st. Shareholders of record on Friday, June 28th will be paid a $0.80 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $3.20 annualized dividend and a dividend yield of 0.94%. Stryker’s payout ratio is presently 36.53%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.